NCT03324360View on ClinicalTrials.gov

Role of Hyperpolarized 13C-Pyruvate MR Spectroscopy in Patients With Intracranial Metastasis Treated With (SRS)

PHASE1RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Brain Metastases
Interventions
DRUG

Hyperpolarized 13C-Pyruvate

MRI with Hyperpolarized 13C-Pyruvate Injection

Trial Locations (1)

M4N 3M5

RECRUITING

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER